CD274 and neoplasm: Key markers include PD-L1 expression, blood-based tumor mutational burden (bTMB), microsatellite instability (MSI), DNA damage repair (DDR) mechanisms, and tumor-infiltrating lymphocytes (TILs) (13, 14).